Total Payments
$16,903
2024 Payments
$15,351
Companies
29
Transactions
72
Medicare Patients
13,957
Medicare Billing
$620,027
Payment Breakdown by Category
Other$15,300 (90.5%)
Food & Beverage$1,533 (9.1%)
Education$43.89 (0.3%)
Travel$25.99 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $15,300 | 1 | 90.5% |
| Food and Beverage | $1,533 | 65 | 9.1% |
| Education | $43.89 | 3 | 0.3% |
| Travel and Lodging | $25.99 | 2 | 0.2% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$16,903
71 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Central Indiana URS Consumables, LLC | $15,300 | 2 | $0 (2024) |
| Intuitive Surgical, Inc. | $505.00 | 7 | $0 (2018) |
| Dendreon Pharmaceuticals LLC | $117.89 | 2 | $0 (2017) |
| PFIZER INC. | $104.52 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $96.09 | 7 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $77.98 | 6 | $0 (2020) |
| Rochester Medical Corporation | $63.08 | 4 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $60.50 | 3 | $0 (2017) |
| Amgen Inc. | $52.29 | 3 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $45.49 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,351 | 4 | Central Indiana URS Consumables, LLC ($15,300) |
| 2023 | $149.02 | 7 | Sumitomo Pharma America, Inc. ($44.26) |
| 2022 | $58.94 | 3 | Amgen Inc. ($28.71) |
| 2020 | $40.11 | 3 | Ferring Pharmaceuticals Inc. ($14.85) |
| 2019 | $151.85 | 11 | PFIZER INC. ($67.48) |
| 2018 | $653.03 | 21 | Intuitive Surgical, Inc. ($434.04) |
| 2017 | $499.23 | 23 | Dendreon Pharmaceuticals LLC ($117.89) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Central Indiana URS Consumables, LLC | Dornier MedTech (Medical Supply), CVAC Aspiration System, Dornier MedTech | Long term medical supply or device loan | Stock option | $15,300.00 | General |
| Category: Ureteroscopy | ||||||
| 09/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Neuromodulation | ||||||
| 2024 | Central Indiana URS Consumables, LLC | — | — | — | $0.00 | Ownership |
| 11/16/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| 11/03/2023 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: HORMONE THERAPY | ||||||
| 06/22/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $15.11 | General |
| 06/15/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/12/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Genetic Disease | ||||||
| 02/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Urology | ||||||
| 12/08/2022 | Sanara MedTech Inc. | CellerateRx (Device) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Collagen based wound filler | ||||||
| 10/26/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Urology | ||||||
| 10/20/2022 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Oncology | ||||||
| 02/27/2020 | Clinigen Inc | Proleukin (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Metastatic Renal Cell Carcinoma or Melanoma | ||||||
| 02/06/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: UROLOGY | ||||||
| 01/03/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Oncology | ||||||
| 11/08/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2019 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Bone Health | ||||||
| 11/01/2019 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: UROLOGY | ||||||
| 08/02/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Diagnostic Imaging | ||||||
| 07/02/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2019 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2019 | PFIZER INC. | GELFOAM (Device) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: HEMOSTAT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,406 | 4,039 | $584,664 | $128,760 |
| 2022 | 35 | 3,304 | 3,971 | $554,200 | $120,413 |
| 2021 | 51 | 3,867 | 5,288 | $868,339 | $198,045 |
| 2020 | 48 | 3,380 | 4,818 | $762,709 | $172,809 |
Total Patients
13,957
Total Services
18,116
Medicare Billing
$620,027
Procedure Codes
174
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 350 | $89,950 | $29,216 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 118 | 118 | $46,492 | $13,171 | 28.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 72 | 84 | $65,352 | $13,039 | 20.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 611 | 654 | $49,704 | $11,749 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 148 | $25,900 | $8,659 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 140 | $24,360 | $7,632 | 31.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 48 | $23,568 | $6,212 | 26.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 117 | $13,923 | $4,541 | 32.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 137 | 155 | $16,430 | $3,850 | 23.4% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 407 | 438 | $14,454 | $3,451 | 23.9% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 68 | $14,212 | $3,077 | 21.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 23 | 26 | $61,875 | $3,021 | 4.9% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 255 | 301 | $10,836 | $2,537 | 23.4% |
| 87088 | Bacterial urine culture | Office | 2023 | 261 | 318 | $10,812 | $2,508 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $7,453 | $2,117 | 28.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 13 | 13 | $46,550 | $2,075 | 4.5% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 61 | 61 | $12,505 | $1,734 | 13.9% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 72 | 73 | $5,548 | $1,299 | 23.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 68 | 68 | $5,100 | $1,287 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,972 | $1,161 | 29.2% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 39 | 39 | $4,485 | $1,018 | 22.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 47 | 48 | $4,272 | $983.68 | 23.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 62 | 80 | $3,440 | $828.00 | 24.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 258 | 347 | $3,470 | $757.98 | 21.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 13 | 13 | $9,490 | $560.56 | 5.9% |
About Dr. Charles Schwab, MD
Dr. Charles Schwab, MD is a Urology healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669412656.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Schwab, MD has received a total of $16,903 in payments from pharmaceutical and medical device companies, with $15,351 received in 2024. These payments were reported across 72 transactions from 29 companies. The most common payment nature is "Long term medical supply or device loan" ($15,300).
As a Medicare-enrolled provider, Schwab has provided services to 13,957 Medicare beneficiaries, totaling 18,116 services with total Medicare billing of $620,027. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Greenwood, IN
- Active Since 06/07/2006
- Last Updated 01/19/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1669412656
Products in Payments
- Dornier MedTech (Medical Supply) $15,300
- Da Vinci Surgical System (Device) $505.00
- PROVENGE (Drug) $178.39
- XTANDI (Drug) $120.22
- Xofigo (Drug) $77.98
- Myrbetriq (Drug) $51.95
- FIRMAGON (Drug) $45.49
- ZYTIGA (Drug) $40.82
- JEVTANA (Drug) $39.57
- Proleukin (Drug) $38.75
- MAGIC3 (Device) $36.75
- EXPAREL (Drug) $33.96
- MYRBETRIQ (Drug) $29.50
- XGEVA (Biological) $28.71
- PROCLAIM (Device) $28.27
- Androgel (Drug) $27.89
- JELMYTO (Drug) $27.68
- SUTENT (Drug) $26.87
- BMD-Magic3 Catheter (Device) $26.33
- GEMTESA (Drug) $24.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Greenwood
Dr. Eugene Cone, M.d, M.D
Urology — Payments: $57,489
Urology $57,489
Bradley Orris, M.d, M.D
Urology — Payments: $27,697
Urology $27,697
David Gilley, Md, MD
Urology — Payments: $23,775
Urology $23,775
Brian Orr, Md, MD
Urology — Payments: $22,029
Urology $22,029
Dr. Todd Hansen, M.d, M.D
Urology — Payments: $5,652
Urology $5,652
Herman Parramore, M.d, M.D
Urology — Payments: $5,576
Urology $5,576